News About: Pharm. Industry
GSK Vice President Tae-joon Yeon move to Home Plus
Vice President Tae-joon Yeon who led the Foreign Cooperation at GSK was decided to move to Home Plus.
Home Plus announced establishment of a foreign cooperation department for foreign cooperation, promotion and cris...
Listed pharmaceuticals’ foreigner-owned stocks exceeded 20%
It was observed there were the total 6 public pharmaceutical companies having more than 20% of foreigner-owned stocks, such as Yuhan Corporation and Samjin Pharm.
According to the Yakup Shinmoon’s(www.yakup.com) anal...
For past 5 years, domestic companies suffer while multinational ones cruise
Domestic pharmaceutical companies were known to record slow performances in EDI for the past 5 years.
On the other hand, multinational pharmaceutical companies generally had high performances; for example, Pfizer kep...
Chong Kun Dang gears up on first generic of ‘Revlimid’ recording KRW 7 trillionChong Kun Dang was approved to conduct bioequivalent tests for approval of the first generic of ‘Revlimid(generic name: lenalidomide, Celgene),’ a multiple myeloma therapy whose...
|
Sales licenses of Agrylin & Effient transferred to respective Shire & Daiichi Sankyo
In the 2nd half of the year, selling companies of the essential thrombocytosis therapy, ‘Agrylin’ and the antithrombotic therapy, ‘Effient,’ will be changed.
So far, Agrylin and Effient were sold by Yuhan Corporation...
Last year’s pharmaceutical exports record USD 2.95 billion increased by 22%
The last year’s pharmaceutical manufacturing performance was increased by 3.4% to KRW 16.9699 trillion compared with the year of 2014. Moreover, the pharmaceutical exports and imports were recorded USD 2.95 billion an...
“Who’s Young-ran Kim?” Act known by big pharmas’ headquarters
Not long ago, an officer from a multinational pharmaceutical company’s headquarters asked a question to a reporter.
“Who’s Young-ran Kim?”
The ‘Anti-Corruption and Bribery Prohibition Act’ which will be enforced on ...
KPMA decides to take away KRW-50-billion-rebate Pharmaking’s membership
The Korea Pharmaceutical Manufacturers Association(KPMA) has led themselves to be strict on pharmaceutical companies which get caught for rebates.
The KPMA decided to lay an item of the disciplinary action to first p...
Celltrion records highest 63% in gross-profit ratio in 1st quarter
Among listed pharmaceutical companies, Celltrion recorded the highest, 63%, in the gross-profit ratio, and Hwail Pharm, active pharmaceutical ingredient company, recorded the lowest, 14%.
According to the Yakup Shi...
Brexit might benefit pharmaceutical companies with high export proportions
Although the British withdrawal from the EU has raised sense of crisis, most believe it will not bring a huge impact on the domestic pharmaceutical industry. Pharmaceutical companies with high exports, on the other ha...
